S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

实时更新: TherapeuticsMD Inc [TXMD]

交易所: NASDAQ 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
最后更新时间4 May 2024 @ 04:00

0.53% $ 1.880

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):
Profile picture for TherapeuticsMD Inc

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system...

Stats
今日成交量 24 483.00
平均成交量 22 872.00
市值 21.68M
EPS $-0.130 ( 2023-11-13 )
下一个收益日期 ( $0 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.54
ATR14 $0.0150 (0.79%)
Insider Trading
Date Person Action Amount type
2023-12-05 Walker Marlan D Buy 70 000 Common Stock
2023-12-06 Walker Marlan D Sell 14 500 Common Stock
2023-12-07 Walker Marlan D Sell 4 550 Common Stock
2023-12-05 Walker Marlan D Sell 70 000 Restricted Stock Units
2023-11-15 Rubric Capital Management Lp Buy 877 192 Common Stock, par value $0.001 per share ("Common Stock")
INSIDER POWER
77.30
Last 94 transactions
Buy: 1 627 514 | Sell: 264 866

TherapeuticsMD Inc 相关性

10 最正相关
BIOC0.888
YVR0.88
INVE0.879
ARIZ0.871
VERV0.864
POAI0.864
ARVL0.857
ZD0.854
GMDA0.837
ATHN0.836
10 最负相关
GRIN-0.885
DBDR-0.865
ABIO-0.862
CATB-0.86
PPTA-0.859
AMRK-0.857
SGRP-0.855
MOTNU-0.851
AFINP-0.849
GALT-0.849

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

TherapeuticsMD Inc 财务报表

Annual 2023
营收: $1.30M
毛利润: $380 000 (29.19 %)
EPS: $-0.980
FY 2023
营收: $1.30M
毛利润: $380 000 (29.19 %)
EPS: $-0.980
FY 2022
营收: $69.96M
毛利润: $68.57M (98.00 %)
EPS: $-10.35
FY 2021
营收: $86.95M
毛利润: $68.11M (78.33 %)
EPS: $-0.625

Financial Reports:

No articles found.

TherapeuticsMD Inc

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。